Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.058 AUD | -3.33% | +7.41% | -40.21% |
Apr. 05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
Feb. 26 | Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-40.21% | 35.59M | |
+2.93% | 108B | |
+7.02% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- BIT Stock
- News Biotron Limited
- Biotron Begins Phase Two COVID-19 Trial for Antiviral Medication